Navigation Links
Market Demand and Innovation in Germany Propel Industrial Biotechnology Growth

BERLIN, June 25, 2010 /PRNewswire/ -- Industrial biotechnology is expected to grow worldwide by 10 to 20 percent per year through 2020. Germany has already established the preconditions to accelerate R&D and commercialization in this nascent industry, making it an ideal site for companies looking to benefit from growing market demand. Representatives from Germany Trade & Invest will be on hand at this year's World Congress on Industrial Biotechnology & Bioprocessing, taking place from June 27 - 30 in Washington, DC, to discuss business opportunities in Germany.

More than 40 percent of small and medium enterprises (SMEs) active in industrial biotechnology in Europe are located in Germany. Alongside these highly dynamic SMEs, several large companies, primarily active in the chemical industry, are also conducting industrial biotechnology R&D in Germany. This high level of activity is a testament to the attractive conditions in Germany.

Currently global revenues for goods produced using industrial biotechnology are estimated between EUR 50 and 60 billion annually. By 2030 this figure is expected to grow to a volume of roughly EUR 300 billion, according to the "Cologne Paper" by the Council of the European Union. Growth projections in Germany are largely based on the country's collective environmental awareness and increasing preference for environmentally-friendly products. At the same time, products manufactured using these new processes promise savings in certain areas, such as production costs and life-cycle assessments. In the case of bioplastics, for example, cost-intensive recycling processes are no longer necessary.

Industrial Biotechnology - Using "Nature's Toolbox"

Industrial biotechnology utilizes "Nature's Toolbox" - microorganisms and enzymes - to create new industrial processes. The chemical industry is currently highly advanced in implementing industrial biotechnology processes, while the food and beverage as well as the pharmaceutical industries are also using this innovative technology. Products include biopolymers (packaging materials), fine and specialty chemicals (amino acids), and consumer goods (detergents and food additives).

Germany Trade & Invest will have industry experts on hand at booth 1200 together with partners from industry and R&D. These partners include industrial biotechnology clusters and companies as well as chemical parks. Industrial biotechnology clusters form a nationwide network working together to accelerate commercialization processes. These clusters represent various players from research institutes and industry. Chemical parks provide a unique flagship model. They offer a full-service infrastructure and enable companies to share overhead and integrate with potential partners. This in turn lowers costs and accelerates the potential for commercialization of new technologies.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

    Germany Trade & Invest
    Eva Henkel
    T: +49(0)30-200099-173
    F: +49(0)30-200099-111

SOURCE Germany Trade and Invest
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
2. World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets
3. Top 10 Drug Delivery Technologies (2010 - 2015): MarketsandMarkets
4. Diabetes Care Devices Market In Brazil, Russia, India, China (BRIC) Worth $570.56 Million In 2014
5. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
6. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
7. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
8. RBC Life Sciences Fills Newly Created Vice President of Sales and Marketing Position With Industry Veteran
9. Highly Regarded Medical Writer Joins Avant Healthcare Marketing Team
10. Healthcare Data Solutions Announces New Healthcare eMarketing Webinar
11. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
Post Your Comments:
(Date:10/13/2015)... the United States , ... represents about 14% of all new cases of kidney cancer.   ... Canada and Europe .  PRCC represents ... --> Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces ... AB (publ) ("AstraZeneca") have completed enrolment in a global Phase II ...
(Date:10/12/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, ... filed against the Company has been dismissed by the ... and CEO, stated, "As we suspected, this case was ...
(Date:10/12/2015)... 12, 2015 cell surface marker detection ... 2022, according to a new report by Grand View Research, ... in incidence of oncology diseases and other cell-associated disorders. ... to reach USD 6.49 billion by 2022, according to a ... demand can be attributed to rise in incidence of oncology ...
(Date:10/12/2015)... DIEGO , Oct. 12, 2015  Patara ... debilitating allergic and inflammatory diseases and conditions, today ... A preferred stock financing. Concurrent with the close ... entered into a Loan and Security Agreement with ... up to $7 million. Patara will use the ...
Breaking Biology Technology:
(Date:9/29/2015)... -- News facts: , ... , Minimized design shrinks PC footprint , ... embedded Fujitsu PalmSecure authentication enable enterprises to realize benefits ... that good things come in small packages, with the ... desktop and mobile portfolio. Featuring workplace design that favors ...
(Date:9/28/2015)... YORK , Sept. 28, 2015  The ... respiration rate and body temperature, is an essential ... can be indicators of deterioration in a patient,s ... hospital, vital signs are typically taken during routine ... hours. If a patient deteriorates between these observation ...
(Date:9/28/2015)... Synaptics Inc. (NASDAQ: SYNA ), the ... Lenovo has selected Synaptics , Natural ID ™ ... smartphone, the Vibe P1. The new Vibe P1 ... and provide swift access to applications and mobile payments ... FS4202 sensor solution utilizes AES256-bit encryption of the fingerprint ...
Breaking Biology News(10 mins):